119 related articles for article (PubMed ID: 20943306)
1. Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms.
Zubrienė A; Gutkowska M; Matulienė J; Chaleckis R; Michailovienė V; Voroncova A; Venclovas C; Zylicz A; Zylicz M; Matulis D
Biophys Chem; 2010 Nov; 152(1-3):153-63. PubMed ID: 20943306
[TBL] [Abstract][Full Text] [Related]
2. Measurement of nanomolar dissociation constants by titration calorimetry and thermal shift assay - radicicol binding to Hsp90 and ethoxzolamide binding to CAII.
Zubrienė A; Matulienė J; Baranauskienė L; Jachno J; Torresan J; Michailovienė V; Cimmperman P; Matulis D
Int J Mol Sci; 2009 Jun; 10(6):2662-2680. PubMed ID: 19582223
[TBL] [Abstract][Full Text] [Related]
3. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones.
Schulte TW; Akinaga S; Murakata T; Agatsuma T; Sugimoto S; Nakano H; Lee YS; Simen BB; Argon Y; Felts S; Toft DO; Neckers LM; Sharma SV
Mol Endocrinol; 1999 Sep; 13(9):1435-48. PubMed ID: 10478836
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamics of aryl-dihydroxyphenyl-thiadiazole binding to human Hsp90.
Kazlauskas E; Petrikaitė V; Michailovienė V; Revuckienė J; Matulienė J; Grinius L; Matulis D
PLoS One; 2012; 7(5):e36899. PubMed ID: 22655030
[TBL] [Abstract][Full Text] [Related]
5. Expressed as the sole Hsp90 of yeast, the alpha and beta isoforms of human Hsp90 differ with regard to their capacities for activation of certain client proteins, whereas only Hsp90beta generates sensitivity to the Hsp90 inhibitor radicicol.
Millson SH; Truman AW; Rácz A; Hu B; Panaretou B; Nuttall J; Mollapour M; Söti C; Piper PW
FEBS J; 2007 Sep; 274(17):4453-63. PubMed ID: 17681020
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Hsp90
Magwenyane AM; Mhlongo NN; Lawal MM; Amoako DG; Somboro AM; Sosibo SC; Shunmugam L; Khan RB; Kumalo HM
Molecules; 2020 Apr; 25(8):. PubMed ID: 32295059
[TBL] [Abstract][Full Text] [Related]
7. The HSP90 binding mode of a radicicol-like E-oxime determined by docking, binding free energy estimations, and NMR 15N chemical shifts.
Spichty M; Taly A; Hagn F; Kessler H; Barluenga S; Winssinger N; Karplus M
Biophys Chem; 2009 Aug; 143(3):111-23. PubMed ID: 19482409
[TBL] [Abstract][Full Text] [Related]
8. Conformational dynamics of the molecular chaperone Hsp90 in complexes with a co-chaperone and anticancer drugs.
Phillips JJ; Yao ZP; Zhang W; McLaughlin S; Laue ED; Robinson CV; Jackson SE
J Mol Biol; 2007 Oct; 372(5):1189-203. PubMed ID: 17764690
[TBL] [Abstract][Full Text] [Related]
9. The Hsp90 inhibitor radicicol interacts with the ATP-binding pocket of bacterial sensor kinase PhoQ.
Guarnieri MT; Zhang L; Shen J; Zhao R
J Mol Biol; 2008 May; 379(1):82-93. PubMed ID: 18440021
[TBL] [Abstract][Full Text] [Related]
10. A simple yeast-based system for analyzing inhibitor resistance in the human cancer drug targets Hsp90alpha/beta.
Millson SH; Prodromou C; Piper PW
Biochem Pharmacol; 2010 Jun; 79(11):1581-8. PubMed ID: 20138026
[TBL] [Abstract][Full Text] [Related]
11. Binding of natural and synthetic inhibitors to human heat shock protein 90 and their clinical application.
Petrikaitė V; Matulis D
Medicina (Kaunas); 2011; 47(8):413-20. PubMed ID: 22123555
[TBL] [Abstract][Full Text] [Related]
12. Despite their structural similarities, the cytosolic isoforms of human Hsp90 show different behaviour in thermal unfolding due to their conformation: An FTIR study.
Ausili A
Arch Biochem Biophys; 2023 May; 740():109599. PubMed ID: 37028636
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human carbonic anhydrase XII stability and inhibitor binding.
Jogaitė V; Zubrienė A; Michailovienė V; Gylytė J; Morkūnaitė V; Matulis D
Bioorg Med Chem; 2013 Mar; 21(6):1431-6. PubMed ID: 23159038
[TBL] [Abstract][Full Text] [Related]
14. The energetics of HMG box interactions with DNA: thermodynamics of the DNA binding of the HMG box from mouse sox-5.
Privalov PL; Jelesarov I; Read CM; Dragan AI; Crane-Robinson C
J Mol Biol; 1999 Dec; 294(4):997-1013. PubMed ID: 10588902
[TBL] [Abstract][Full Text] [Related]
15. Relationship among ligand conformations in solution, in the solid state, and at the Hsp90 binding site: geldanamycin and radicicol.
Thepchatri P; Eliseo T; Cicero DO; Myles D; Snyder JP
J Am Chem Soc; 2007 Mar; 129(11):3127-34. PubMed ID: 17323946
[TBL] [Abstract][Full Text] [Related]
16. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Roe SM; Prodromou C; O'Brien R; Ladbury JE; Piper PW; Pearl LH
J Med Chem; 1999 Jan; 42(2):260-6. PubMed ID: 9925731
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the middle domains stabilizes Hsp90α dimer in a closed conformation with high affinity for p23.
Synoradzki K; Miszta P; Kazlauskas E; Mickevičiūtė A; Michailovienė V; Matulis D; Filipek S; Bieganowski P
Biol Chem; 2018 Mar; 399(4):337-345. PubMed ID: 29337688
[TBL] [Abstract][Full Text] [Related]
19. Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol.
Sharma SV; Agatsuma T; Nakano H
Oncogene; 1998 May; 16(20):2639-45. PubMed ID: 9632140
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of macrolactam analogues of radicicol and their binding to heat shock protein Hsp90.
Dutton BL; Kitson RR; Parry-Morris S; Roe SM; Prodromou C; Moody CJ
Org Biomol Chem; 2014 Feb; 12(8):1328-40. PubMed ID: 24435512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
